Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US
Go back to Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US| Hikma Pharmaceuticals plc, London Sponsored ADR (AMEX: HKMPY) | Delayed: 44.60 -0.76 (1.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.36 | 52 Week High | $76.47 | |||
| Open | $44.60 | 52 Week Low | $50.73 | |||
| Day High | $44.60 | P/E | N/A | |||
| Day Low | $44.60 | EPS | $0.00 | |||
| Volume | 349 | |||||

